| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | 35F0Y2W16Q |
| InChI Key | MZOITCJKGUIQEI-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C25H37N5O3 |
| Molecular Weight | 455.6 |
| AlogP | 3.61 |
| Hydrogen Bond Acceptor | 5.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 6.0 |
| Polar Surface Area | 90.56 |
| Molecular species | BASE |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 33.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| AGONIST | Serotonin 4 (5-HT4) receptor agonist | Other |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Ion channel
Ligand-gated ion channel
5HT3 receptor
|
- | - | - | 100000 | - | |
|
Ion channel
Voltage-gated ion channel
Potassium channels
Voltage-gated potassium channel
|
- | - | - | - | 11 | |
|
Membrane receptor
Family A G protein-coupled receptor
Small molecule receptor (family A GPCR)
Monoamine receptor
Serotonin receptor
|
1-2 | - | - | 0 | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Gastroparesis | 2 | D018589 | ClinicalTrials |
| Liver Diseases | 1 | D008107 | ClinicalTrials |
| Kidney Diseases | 1 | D007674 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL2402904 |
| DrugBank | DB12725 |
| FDA SRS | 35F0Y2W16Q |
| Guide to Pharmacology | 8426 |
| SureChEMBL | SCHEMBL390795 |
| ZINC | ZINC000043150989 |